Search filters

List of works by Weijin Huang

A Novel High-Throughput Vaccinia Virus Neutralization Assay and Preexisting Immunity in Populations from Different Geographic Regions in China

scientific article published on March 16, 2012

A broadly neutralizing humanized ACE2-targeting antibody against SARS-CoV-2 variants

scientific article published on 17 August 2021

A novel STING agonist-adjuvanted pan-sarbecovirus vaccine elicits potent and durable neutralizing antibody and T cell responses in mice, rabbits and NHPs

scientific article published on 19 January 2022

A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity

scientific article published on 29 July 2020

Analysis of the complete genome sequences of one swine and two human hepatitis E virus genotype 4 strains isolated in Beijing, China

scientific article published on May 16, 2013

Analysis of the evolution, infectivity and antigenicity of circulating rabies virus strains

scientific article published on 01 December 2022

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron BA.1 infection

scientific article published on 02 May 2022

BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

scientific article published in August 2022

Characterization of neutralizing antibody with prophylactic and therapeutic efficacy against SARS-CoV-2 in rhesus monkeys

scientific article published on 13 November 2020

Combining intramuscular and intranasal homologous prime-boost with a chimpanzee adenovirus-based COVID-19 vaccine elicits potent humoral and cellular immune responses in mice

scientific article published in 2022

Comparison of Two High-Throughput Assays for Quantification of Adenovirus Type 5 Neutralizing Antibodies in a Population of Donors in China

scientific article published on May 24, 2012

Comparison of hepatitis E virus genotypes from rabbits and pigs in the same geographic area: No evidence of natural cross-species transmission between the two animals

scientific article published on November 24, 2012

Comparison on Virulence and Immunogenicity of Two Recombinant Vaccinia Vaccines, Tian Tan and Guang9 Strains, Expressing the HIV-1 Envelope Gene

scientific article published on November 6, 2012

Cross-reactivity of eight SARS-CoV-2 variants rationally predicts immunogenicity clustering in sarbecoviruses

scientific article published in 2022

Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses

scientific article published on 06 April 2021

Hepatitis E virus ORF3 antigens derived from genotype 1 and 4 viruses are detected with varying efficiencies by an anti‐hev enzyme immunoassay

scientific article published on February 25, 2011

Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines

scientific article published on 21 May 2021

Identification of a novel DRB1 allele through intergenic recombination between HLA-DRB1 and HLA-DRB3∗02 in a Chinese family

scientific article published on August 2, 2013

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies

scientific article

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

scientific article published on 25 September 2020

Spike-specific circulating T follicular helper cell and cross-neutralizing antibody responses in COVID-19-convalescent individuals

scientific article published on 16 November 2020

Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody

scientific article

Structural characterization of a neutralizing mAb H16.001, a potent candidate for a common potency assay for various HPV16 VLPs

scientific article published on 23 September 2020

Structures of SARS-CoV-2 B.1.351 neutralizing antibodies provide insights into cocktail design against concerning variants

scientific article

Ten emerging SARS-CoV-2 spike variants exhibit variable infectivity, animal tropism, and antibody neutralization

scientific article published on 13 October 2021

The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain

scientific article published on 19 January 2022

The prevalence of neutralizing antibodies against AAV serotype 1 in healthy subjects in China: Implications for gene therapy and vaccines using AAV1 vector

scientific article published on September 1, 2013

Virus Host Protein Interaction Network Analysis Reveals That the HEV ORF3 Protein May Interrupt the Blood Coagulation Process

scientific article published on February 13, 2013